MEREO BIOPHARMA GROUP PLC
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $76.4M
Liabilities Breakdown FY2024
Total Liabilities: $15.4M
Asset Breakdown
Total Assets: $76.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $69.8M | 91.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $257.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $643.0K | 0.8% |
| Other Assets | $5.7M | 7.4% |
Liabilities Breakdown
Total Liabilities: $15.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.4M | 15.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.0M | 84.2% |